A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, with one of the candidates also matching Bristol Myers Squibb and Pfizer’s ...

MADRID -- Stopping oral anticoagulation after successful ablation for atrial fibrillation (AF, Afib) improved outcomes for patients without documented recurrence, the randomized ALONE-AF trial showed.

PHOENIX -- Anticoagulation worked at least as well as antiplatelet medication for stroke prevention after cervical artery dissection, an observational study suggested. Subsequent ischemic stroke was ...

Anticoagulants and antiplatelet drugs eliminate or reduce the risk of blood clots. They can also treat blood clots by breaking them up. Some people may have side effects like increased bruising.

Continuous anticoagulation may effectively reduce the incidence of thromboembolic events in patients with orthopedic trauma, ...

Anticoagulation therapy is used to prevent clot formation. They do not lyse clots but they prevent new clots from forming. Since warfarin takes time to act, heparin and warfarin are usually started ...

High discontinuation rates of OACs in NVAF patients, with 47% stopping within 120 days, highlight adherence challenges. DOACs show a lower risk of discontinuation compared to warfarin, suggesting ...

Anticoagulants are medications that help stop your blood from thickening or “clotting.” Your body does need to be able to clot to help seal wounds inside and outside your body. But unnecessary clots ...